Catalyst Wire Dossier Catalyst Wire Dossier

ALTARGO

retapamulin · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALTARGO, covering 2015-09-23 to 2019-03-15. Get the full timeline:

Most recent: EMA Withdrawn: Altargo (retapamulin) — Glaxo Group Ltd

See pricing